Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "polymerase, delta 1, catalytic subunit 125kDa pseudogene" (ENSG00000217483; LOC100422453) is annotated as a **pseudogene** of the protein-coding gene POLD1, which encodes DNA polymerase delta 1, the 125kDa catalytic subunit essential for DNA replication and repair[1][2][4]. Unlike the functional POLD1 gene, which is involved in lagging strand DNA synthesis, proofreading, and DNA damage repair, the pseudogene does not produce a protein and has no known biological function, disease association, or drug targeting relevance. Structured drug discovery, biomarker application, and therapeutic intervention all apply to the protein-coding gene POLD1, not its pseudogene LOC100422453. If you seek information on a bona fide drug target, refer to **polymerase (DNA) delta 1, catalytic subunit (POLD1)**, not its pseudogene (ENSG00000217483 / LOC100422453)[1][2][3][4].
None. Pseudogene does not encode any protein, so there is no mechanism of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymerase (DNA) delta 1, catalytic subunit pseudogene (LOC100422453).